Joseph Szustakowski
Vice President of Clinical Development Data Science and AI
Bio:
Joseph D. Szustakowski, Ph.D. is Vice President of Clinical Development Data Science and AI at Genmab, where he leads a team focused on leveraging modern AI technologies to streamline and optimize clinical development processes and programs. His current priorities include AI automation of critical clinical operations workflows, the development of AI agents to support scientists in their day-to-day work, and the use of AI to improve program planning and decision-making. Joseph is also leading Genmab's strategic partnership with Anthropic to deploy enterprise AI solutions across clinical development.
With over 20 years of biopharmaceutical industry experience, Dr. Szustakowski has built and led global, cross-functional teams spanning oncology, hematology, cardiovascular, and immunoscience programs across all phases of drug discovery and development. Prior to Genmab, he served as Vice President of Translational Bioinformatics at Bristol Myers Squibb, and previously held roles of increasing responsibility at Novartis, including building an early industry team focused on clinical trial exploratory biomarker data analysis. He has also served as executive sponsor for pre-competitive real-world data and human genetics consortia, including the UK Biobank Exome Sequencing Consortium and the UK Biobank Pharma Proteomics Project.
Throughout his career, Joseph and his teams have contributed to novel drug targets, precision medicine strategies, and successful regulatory submissions. Their work has been recognized through health authority approvals, high-profile scientific publications (Nature, Nature Genetics, New England Journal of Medicine, etc.), and -- most importantly -- positive feedback from patients who benefited from novel therapies. He holds a Ph.D. in Biomedical Engineering from Boston University, where he served on the Human Genome Project's annotation team and co-authored the landmark 2001 Nature paper describing the first draft of the human genome, and a B.S. in Physics from the State University of New York at Buffalo.